Gastric Cancer Genomics Study Using Reference Human Pangenomes

Overview

Journal Life Sci Alliance

Date 2025 Jan 27

PMID 39870503

Authors

Du Jiao

Xiaorui Dong

Shiyu Fan

Xinyi Liu

Yingyan Yu

Chaochun Wei

Affiliations

Soon will be listed here.

Abstract

A pangenome is the sum of the genetic information of all individuals in a species or a population. Genomics research has been gradually shifted to a paradigm using a pangenome as the reference. However, in disease genomics study, pangenome-based analysis is still in its infancy. In this study, we introduced a graph-based pangenome GGCPan from 185 patients with gastric cancer. We then systematically compared the cancer genomics study results using GGCPan, a linear pangenome GCPan, and the human reference genome as the reference. For small variant detection and microsatellite instability status identification, there is little difference in using three different genomes. Using GGCPan as the reference had a significant advantage in structural variant identification. A total of 24 candidate gastric cancer driver genes were detected using three different reference genomes, of which eight were common and five were detected only based on pangenomes. Our results showed that disease-specific pangenome as a reference is promising and a whole set of tools are still to be developed or improved for disease genomics study in the pangenome era.

References

Boland C, Thibodeau S, Hamilton S, Sidransky D, Eshleman J, Burt R . A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998; 58(22):5248-57. View

Jia P, Yang X, Guo L, Liu B, Lin J, Liang H . MSIsensor-pro: Fast, Accurate, and Matched-normal-sample-free Detection of Microsatellite Instability. Genomics Proteomics Bioinformatics. 2020; 18(1):65-71. PMC: 7393535. DOI: 10.1016/j.gpb.2020.02.001. View

Tian X, Li R, Fu W, Li Y, Wang X, Li M . Building a sequence map of the pig pan-genome from multiple de novo assemblies and Hi-C data. Sci China Life Sci. 2019; 63(5):750-763. DOI: 10.1007/s11427-019-9551-7. View

Li R, Li Y, Zheng H, Luo R, Zhu H, Li Q . Building the sequence map of the human pan-genome. Nat Biotechnol. 2009; 28(1):57-63. DOI: 10.1038/nbt.1596. View

Hickey G, Monlong J, Ebler J, Novak A, Eizenga J, Gao Y . Pangenome graph construction from genome alignments with Minigraph-Cactus. Nat Biotechnol. 2023; 42(4):663-673. PMC: 10638906. DOI: 10.1038/s41587-023-01793-w. View

Shi J, Tian Z, Lai J, Huang X . Plant pan-genomics and its applications. Mol Plant. 2022; 16(1):168-186. DOI: 10.1016/j.molp.2022.12.009. View

Lawrence M, Stojanov P, Polak P, Kryukov G, Cibulskis K, Sivachenko A . Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013; 499(7457):214-218. PMC: 3919509. DOI: 10.1038/nature12213. View

Rausch T, Zichner T, Schlattl A, Stutz A, Benes V, Korbel J . DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics. 2012; 28(18):i333-i339. PMC: 3436805. DOI: 10.1093/bioinformatics/bts378. View

Zook J, Hansen N, Olson N, Chapman L, Mullikin J, Xiao C . A robust benchmark for detection of germline large deletions and insertions. Nat Biotechnol. 2020; 38(11):1347-1355. PMC: 8454654. DOI: 10.1038/s41587-020-0538-8. View

10.

Liao W, Asri M, Ebler J, Doerr D, Haukness M, Hickey G . A draft human pangenome reference. Nature. 2023; 617(7960):312-324. PMC: 10172123. DOI: 10.1038/s41586-023-05896-x. View

11.

Mermel C, Schumacher S, Hill B, Meyerson M, Beroukhim R, Getz G . GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011; 12(4):R41. PMC: 3218867. DOI: 10.1186/gb-2011-12-4-r41. View

12.

Pritt J, Chen N, Langmead B . FORGe: prioritizing variants for graph genomes. Genome Biol. 2018; 19(1):220. PMC: 6296055. DOI: 10.1186/s13059-018-1595-x. View

13.

Liu Y, Liao X, Qin Y, Mo X, Luo S . Identification of as a Prognostic Biomarker in Patients with Gastric Cancer. Biomed Res Int. 2020; 2020:9280841. PMC: 7064826. DOI: 10.1155/2020/9280841. View

14.

Yue W, Dacic S, Sun Q, Landreneau R, Guo M, Zhou W . Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation. Clin Cancer Res. 2007; 13(15 Pt 1):4336-44. DOI: 10.1158/1078-0432.CCR-07-0015. View

15.

Weng R, Lu H, Lin C, Fan C, Lin R, Huang T . Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer. Nat Commun. 2021; 12(1):2163. PMC: 8042060. DOI: 10.1038/s41467-021-22433-4. View

16.

Mu J, Mohiyuddin M, Li J, Asadi N, Gerstein M, Abyzov A . VarSim: a high-fidelity simulation and validation framework for high-throughput genome sequencing with cancer applications. Bioinformatics. 2014; 31(9):1469-71. PMC: 4410653. DOI: 10.1093/bioinformatics/btu828. View

17.

Mayakonda A, Lin D, Assenov Y, Plass C, Koeffler H . Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018; 28(11):1747-1756. PMC: 6211645. DOI: 10.1101/gr.239244.118. View

18.

Li G, Zhai Y, Liu H, Wang Z, Huang R, Jiang H . RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma. Aging (Albany NY). 2020; 12(16):16155-16171. PMC: 7485703. DOI: 10.18632/aging.103596. View

19.

Wang W, Mauleon R, Hu Z, Chebotarov D, Tai S, Wu Z . Genomic variation in 3,010 diverse accessions of Asian cultivated rice. Nature. 2018; 557(7703):43-49. PMC: 6784863. DOI: 10.1038/s41586-018-0063-9. View

20.

Wang T, Antonacci-Fulton L, Howe K, Lawson H, Lucas J, Phillippy A . The Human Pangenome Project: a global resource to map genomic diversity. Nature. 2022; 604(7906):437-446. PMC: 9402379. DOI: 10.1038/s41586-022-04601-8. View